Research Paper Advance Articles
Precision prognostication in breast cancer: unveiling a long non-coding RNA-based model linked to disulfidptosis for tailored immunotherapeutic strategies
Figure 10. DAL-related drug sensitivity analysis. (A) Afuresertib, (B) BI-2536, (C) BMS-345541, (D) Erlotinib, (E) GNE-317, (F) Ipatasertib, (G) IWP-2, (H) KU-55933, (I) Leflunomide, (J) MG-132, (K) Mitoxantrone, (L) MK-2206.